Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,900
Total Claims
$268K
Drug Cost
2,087
Beneficiaries
$128
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+47%
Opioid rate vs peers
67.3% vs 45.9% avg
-73%
Cost per patient vs peers
$128 vs $483 avg
-8%
Brand preference vs peers
3.8% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.3%
Opioid Rate
3,973
Opioid Claims
$145K
Opioid Cost
10.4%
Long-Acting Rate
This provider's opioid prescribing rate of 67.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 225 claims · $136K
Generic: 5,675 claims · $132K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 1,150 | $35K |
| Hydrocodone/Acetaminophen | 1,164 | $26K |
| Oxycodone Myristate | 29 | $15K |
| Naloxegol Oxalate | 23 | $14K |
| Buprenorphine Hcl | 14 | $12K |
| Oxycodone Hcl | 497 | $10K |
| Fentanyl | 71 | $9,828 |
| Gabapentin | 467 | $7,327 |
| Pregabalin | 210 | $6,751 |
| Morphine Sulfate | 235 | $6,538 |
| Buprenorphine | 21 | $5,497 |
| Tramadol Hcl | 499 | $3,282 |
| Morphine Sulfate | 92 | $2,636 |
| Methocarbamol | 192 | $2,603 |
| Tizanidine Hcl | 179 | $1,949 |
Prescribing Profile
34
Unique Drugs
21.0
Anomaly Score
Patient Profile
75
Avg Age
62%
Female
1.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About